
Please try another search
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Name | Age | Since | Title |
---|---|---|---|
Barbara A. Kosacz | 66 | 2019 | Independent Director |
Heather L. Franklin | 58 | 2021 | Independent Director |
Natasha A. Hernday | 52 | 2020 | Independent Director |
Owen P. Hughes | 49 | 2023 | CEO & Director |
Matthew D. Perry | 51 | 2017 | Independent Director |
Joseph M. Limber | 71 | 2012 | Independent Director |
Jack L. Wyszomierski | 68 | 2010 | Independent Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review